IN THIS MONTH'S ISSUE

• Impeachment Halts Health Policy Advancement As Coronavirus Spreads

  As the impeachment trial of President Donald Trump dragged into the latter half of the second week, the wheels of healthcare policy development have ground to a halt.

• A Global Biotech Player From Down Under

  “The other part of being a CEO of a listed company is all about investors, and that was an uphill learning curve for me because I’d never dealt with that aspect,” explains Imugene’s CEO Leslie Chong.

• 3 Ways Pharma Manufacturers Can Foster Patient Trust

  At best, the current relationship between patients and pharma manufacturers is nearly nonexistent. At worst, it’s skeptical. Most of that skepticism is due to a communication gap. Here are three ways to improve that.

• The Ins And Outs Of Board Service: What We Now Know

  Twenty relative strangers stepped into a conference room at George Washington University (GWU) with one common goal: learn as much as they could about board directorships in order to better serve as future board members.

• Demographically Appropriate Policies Deliver Sustainable Care And Healthy Populations

  Are current healthcare policies effective to keep future generations of Americans physically, biologically, economically, and emotionally secure? Probably not, so changes need to be made.